Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the 'Company”), a clinical stage pharmaceutical company, today announced ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Research, Development and Innovation (RDI) scheme targets long-gestation, high-risk technologies via flexible capital routed ...

This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Coll ...

Sachin Dear Sachin, Bachelor of Business Administration (BBA) will provide a solid foundation for understanding business ...

Designed to be flexible and future-focused, these programmes incorporate NEP’s multiple-entry and exit options, allowing ...

Israel’s technological rise is shaped by the strategic choices of global capital. In 2022, $22 billion in foreign direct ...

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO’s ...

NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

The registered direct offering and concurrent private placement are each expected to close on or about July 3, 2025, subject ...